查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1800203

全球疟疾诊断市场 - 预测至 2025-2030 年

Global Malaria Diagnostics Market - Forecasts fom 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 142 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

疟疾诊断市场预计将从 2025 年的 710,504,000 美元成长到 2030 年的 908,749,000 美元，复合年增长率为 5.05%。

疟疾诊断市场蓬勃发展，因为早期准确诊断对于控制这种疾病至关重要。如果不及时治疗，疟疾会导致高发病率和高死亡率。高品质的诊断试剂套件，包括分子诊断和快速诊断检测 (RDT)，对于有效控制疾病至关重要。技术进步和政府资金的增加推动了疟疾诊断市场的发展，但部分地区认知度较低，这给市场带来了挑战。本概述重点介绍目前的趋势、驱动因素、限制因素和关键参与企业，不包括2023年之前的发展。

市场驱动因素

疟疾诊断市场的关键驱动力在于诊断技术的进步，尤其是快速诊断（RDT）和分子诊断技术，这些技术能够快速且准确地检测疟疾。这些创新技术能够及时治疗并改善患者预后，尤其是在感染率较高的地区。开发中国家政府增加对疟疾研究和宣传宣传活动的资助也是一个重要的成长要素因素。这些倡议旨在提高诊断的可近性，并教育社区，尤其是在疟疾流行地区，早期检测的重要性。全球疟疾负担持续凸显了对高效诊断工具的需求，进一步推动了市场需求。

市场限制

儘管疟疾诊断市场具有成长潜力，但由于某些地区（尤其是在疟疾流行的新兴国家）公众认知度较低，该市场仍面临挑战。对诊断工具及其益处的了解不足，可能会延迟其应用，并阻碍有效的疾病控制。此外，物流的挑战，例如偏远地区医疗基础设施不足，也可能限制人们获得先进诊断工具，并限制市场扩张。透过完善教育和分销网络来克服这些障碍，对于持续成长至关重要。

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 经营状况

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策法规
  • 策略建议

第四章 技术展望

5. 疟疾诊断市场（依技术）

  • 介绍
  • 快速诊断测试（RDT）
  • 显微镜
  • 分子诊断
  • 血清学检测
  • 其他的

第六章 疟疾诊断市场（依最终使用者）

  • 介绍
  • 医院和诊所
  • 诊断实验室
  • 研究所
  • 非政府组织和政府健康项目

7. 疟疾诊断市场（依通路）

  • 介绍
  • 直接竞标和设施销售
  • 零售和私营部门

8. 疟疾诊断市场（按地区）

  • 介绍
  • 北美洲
    • 依技术
    • 按最终用户
    • 按分销管道
    • 按国家
      • 美国
      • 加拿大
      • 墨西哥
  • 南美洲
    • 依技术
    • 按最终用户
    • 按分销管道
    • 按国家
      • 巴西
      • 阿根廷
      • 其他的
  • 欧洲
    • 依技术
    • 按最终用户
    • 按分销管道
    • 按国家
      • 英国
      • 德国
      • 法国
      • 西班牙
      • 其他的
  • 中东和非洲
    • 依技术
    • 按最终用户
    • 按分销管道
    • 按国家
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 其他的
  • 亚太地区
    • 依技术
    • 按最终用户
    • 按分销管道
    • 按国家
      • 中国
      • 日本
      • 韩国
      • 印度
      • 印尼
      • 泰国
      • 其他的

第九章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十章：公司简介

  • Motic（Xiamen）Electric Group Co., Ltd.
  • Sight Diagnostics Ltd.
  • bioMerieux SA
  • Intellectual Ventures Laboratory, LLC
  • Access Bio. Inc.
  • Sysmex Europe GmbH
  • Abbott Laboratories
  • Meridian Bioscience, Inc.
  • QuantuMDx Group Ltd.
  • Hemex Health, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • Premier Medical Corporation Pvt. Ltd.

第十一章 附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061611645

The Global Malaria Diagnostics Market is expected to grow from USD 710.504 million in 2025 to USD 908.749 million in 2030, at a CAGR of 5.05%.

The malaria diagnostics market is experiencing growth driven by the critical need for early and accurate diagnosis to manage a disease that causes significant morbidity and mortality if untreated. High-quality diagnostic kits, including molecular diagnostics and rapid diagnostic tests (RDTs), are essential for effective disease management. The market is supported by technological advancements and increased government funding, though low awareness in some regions poses challenges. This summary focuses on current trends, drivers, restraints, and key players, excluding developments prior to 2023.

Market Drivers

The primary driver of the malaria diagnostics market is the advancement in diagnostic technologies, particularly RDTs and molecular diagnostics, which enable rapid and precise detection of malaria. These innovations improve patient outcomes by facilitating timely treatment, especially in high-burden regions. Increased government funding for malaria research and awareness campaigns in developing countries is another key growth factor. These initiatives aim to enhance access to diagnostics and educate communities about the importance of early detection, particularly in endemic areas. The global burden of malaria continues to underscore the need for efficient diagnostic tools, further propelling market demand.

Market Restraints

Despite its growth potential, the malaria diagnostics market faces challenges due to low awareness among populations in certain regions, particularly in developing countries where malaria is prevalent. Limited understanding of diagnostic tools and their benefits can delay adoption and hinder effective disease management. Additionally, logistical challenges, such as inadequate healthcare infrastructure in remote areas, may restrict access to advanced diagnostics, limiting market expansion. Addressing these barriers through education and improved distribution networks is essential for sustained growth.

Market Segmentation

By Diagnostic Type

The market is segmented into molecular diagnostics and RDTs, with RDTs dominating due to their ease of use, affordability, and suitability for point-of-care testing in resource-limited settings. Molecular diagnostics, while more precise, are gaining traction in advanced healthcare systems for their ability to detect low-level infections. Both segments are critical to addressing diverse diagnostic needs across global markets.

By Geography

The malaria diagnostics market is concentrated in high-burden regions, particularly Sub-Saharan Africa and parts of Asia, where malaria prevalence drives demand. Africa remains the largest market due to its significant disease burden and increasing government-led initiatives. The Asia-Pacific region is also growing, supported by rising investments in healthcare infrastructure and awareness programs. Developed regions like North America and Europe contribute through research and development of advanced diagnostic technologies.

Key Industry Players

Major players in the malaria diagnostics market include Motic (Xiamen) Electric Group Co., Ltd., Sight Diagnostics Ltd., bioMerieux SA, Intellectual Ventures Laboratory, LLC, Access Bio, Inc., Sysmex Europe GmbH, Abbott Laboratories, Meridian Bioscience, Inc., QuantuMDx Group Ltd., Hemex Health, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., and Premier Medical Corporation Pvt. Ltd. These companies are driving innovation in diagnostic technologies and expanding access to testing solutions.

The malaria diagnostics market is poised for growth, driven by technological advancements and increased funding for malaria control. Low awareness and logistical challenges remain hurdles, particularly in endemic regions. With a focus on RDTs and molecular diagnostics, and strong growth in Africa and Asia-Pacific, the market is well-positioned to address global malaria challenges, provided stakeholders prioritize education and accessibility.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2020 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Malaria Diagnostics Market Segmentation:

By Technology

  • Rapid Diagnostic Tests (RDTs)
  • Microscopy
  • Molecular Diagnostics
  • Serology-based Tests
  • Other Technologies

By End-Users

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • NGOs and Government Health Programs

By Distribution Channel

  • Direct Tenders & Institutional Sales
  • Retail and Private

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. MALARIA DIAGNOSTICS MARKET BY TECHNOLOGY

  • 5.1. Introduction
  • 5.2. Rapid Diagnostic Tests (RDTs)
  • 5.3. Microscopy
  • 5.4. Molecular Diagnostics
  • 5.5. Serology-based Tests
  • 5.6. Other Technologies

6. MALARIA DIAGNOSTICS MARKET BY END-USERS

  • 6.1. Introduction
  • 6.2. Hospitals and Clinics
  • 6.3. Diagnostic Laboratories
  • 6.4. Research Institutes
  • 6.5. NGOs and Government Health Programs

7. MALARIA DIAGNOSTICS MARKET BY DISTRIBUTION CHANNEL

  • 7.1. Introduction
  • 7.2. Direct Tenders & Institutional Sales
  • 7.3. Retail and Private

8. MALARIA DIAGNOSTICS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Technology
    • 8.2.2. By End-Users
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Technology
    • 8.3.2. By End-Users
    • 8.3.3. By Distribution Channel
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Technology
    • 8.4.2. By End-Users
    • 8.4.3. By Distribution Channel
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Technology
    • 8.5.2. By End-Users
    • 8.5.3. By Distribution Channel
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Technology
    • 8.6.2. By End-Users
    • 8.6.3. By Distribution Channel
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. South Korea
      • 8.6.4.4. India
      • 8.6.4.5. Indonesia
      • 8.6.4.6. Thailand
      • 8.6.4.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Motic (Xiamen) Electric Group Co., Ltd.
  • 10.2. Sight Diagnostics Ltd.
  • 10.3. bioMerieux SA
  • 10.4. Intellectual Ventures Laboratory, LLC
  • 10.5. Access Bio. Inc.
  • 10.6. Sysmex Europe GmbH
  • 10.7. Abbott Laboratories
  • 10.8. Meridian Bioscience, Inc.
  • 10.9. QuantuMDx Group Ltd.
  • 10.10. Hemex Health, Inc.
  • 10.11. F. Hoffmann-La Roche Ltd.
  • 10.12. Bio-Rad Laboratories, Inc.
  • 10.13. Thermo Fisher Scientific Inc.
  • 10.14. Premier Medical Corporation Pvt. Ltd.

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations